• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

样本采集质量改进提高了定量粪便免疫化学检测在结直肠癌筛查中的诊断准确性:一项试点研究。

Quality Improvement of Sample Collection Increases the Diagnostic Accuracy of Quantitative Fecal Immunochemical Test in Colorectal Cancer Screening: A Pilot Study.

作者信息

Zhou Ru-Chen, Wang Pei-Zhu, Li Yue-Yue, Zhang Yan, Ma Ming-Jun, Meng Fan-Yi, Liu Chao, Yang Xiao-Yun, Lv Ming, Zuo Xiu-Li, Li Yan-Qing

机构信息

Department of Gastroenterology, Qilu Hospital, Shandong University, Jinan, China.

Laboratory of Translational Gastroenterology, Qilu Hospital, Shandong University, Jinan, China.

出版信息

Front Med (Lausanne). 2021 Oct 26;8:762560. doi: 10.3389/fmed.2021.762560. eCollection 2021.

DOI:10.3389/fmed.2021.762560
PMID:34765625
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8575757/
Abstract

The diagnostic efficiency of the quantitative fecal immunochemical test (qFIT) has large variations in colorectal cancer (CRC) screening. We aimed to explore whether the practical sample collection operant training could improve the diagnostic accuracy of the qFIT in CRC screening. Moderate-/high-risk individuals aged 50-75 years old were invited to participate in a prospective observational study between July 2020 and March 2021. Participants took a qFIT sample without fecal sample collection operant training in advance and then completed another qFIT sample after the operant training. The primary outcome was the sensitivity and specificity of the qFITs for CRC and advanced colorectal neoplasia (ACRN). The secondary outcome was the difference in the area under the curves (AUCs) and the concentrations of the fecal hemoglobin (Hb) between the qFIT without and after the operant training. Out of 913 patients, 81 (8.9%) patients had ACRN, including 25 (2.7%) patients with CRC. For CRC, the sensitivities of the qFIT without and after the operant training at 10 μg/g were 80.4 and 100.0%, respectively, and the specificities were 90.1 and 88.4%, respectively. For ACRN, the sensitivities were 49.4 and 69.1% and the specificities were 91.7 and 91.3%, respectively. The AUC of the qFIT after the operant training was significantly higher than that without the operant training for CRC ( = 0.027) and ACRN ( = 0.001). After the operant training, the concentration of the fecal Hb was significantly higher than that without the operant training ( = 0.009) for ACRN, but there was no significant difference for CRC ( = 0.367). Practical sample collection operant training improves the diagnostic accuracy of the qFIT, which increases the detection of the low concentrations of fecal Hb. Improving the quality of the sample collection could contribute to the diagnostic efficiency of the qFIT in CRC screening.

摘要

定量粪便免疫化学检测(qFIT)在结直肠癌(CRC)筛查中的诊断效率存在很大差异。我们旨在探讨实际的样本采集操作培训是否能提高qFIT在CRC筛查中的诊断准确性。邀请年龄在50 - 75岁的中/高风险个体参加2020年7月至2021年3月的一项前瞻性观察研究。参与者在未提前进行粪便样本采集操作培训的情况下采集一份qFIT样本,然后在操作培训后再完成另一份qFIT样本。主要结局是qFIT对CRC和进展期结直肠肿瘤(ACRN)的敏感性和特异性。次要结局是操作培训前后qFIT的曲线下面积(AUC)差异以及粪便血红蛋白(Hb)浓度差异。在913例患者中,81例(8.9%)患有ACRN,其中25例(2.7%)患有CRC。对于CRC,操作培训前和后qFIT在10μg/g时的敏感性分别为80.4%和100.0%,特异性分别为90.1%和88.4%。对于ACRN,敏感性分别为49.4%和69.1%,特异性分别为91.7%和91.3%。操作培训后qFIT的AUC在CRC(P = 0.027)和ACRN(P = 0.001)方面显著高于未进行操作培训时。对于ACRN,操作培训后粪便Hb浓度显著高于未进行操作培训时(P = 0.009),但对于CRC无显著差异(P = 0.367)。实际的样本采集操作培训提高了qFIT的诊断准确性,增加了低浓度粪便Hb的检测。提高样本采集质量有助于提高qFIT在CRC筛查中的诊断效率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/597c/8575757/18320eea8743/fmed-08-762560-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/597c/8575757/0c159b02bb0a/fmed-08-762560-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/597c/8575757/e43aeeb0a7d7/fmed-08-762560-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/597c/8575757/18320eea8743/fmed-08-762560-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/597c/8575757/0c159b02bb0a/fmed-08-762560-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/597c/8575757/e43aeeb0a7d7/fmed-08-762560-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/597c/8575757/18320eea8743/fmed-08-762560-g0003.jpg

相似文献

1
Quality Improvement of Sample Collection Increases the Diagnostic Accuracy of Quantitative Fecal Immunochemical Test in Colorectal Cancer Screening: A Pilot Study.样本采集质量改进提高了定量粪便免疫化学检测在结直肠癌筛查中的诊断准确性:一项试点研究。
Front Med (Lausanne). 2021 Oct 26;8:762560. doi: 10.3389/fmed.2021.762560. eCollection 2021.
2
Quantitative immunochemical fecal occult blood test for neoplasia in colon cancer screening.定量免疫化学粪便潜血试验在结直肠癌筛查中的应用。
J Dig Dis. 2019 Feb;20(2):78-82. doi: 10.1111/1751-2980.12711. Epub 2019 Mar 10.
3
Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.用于结直肠癌筛查的粪便潜血试验:一项基于证据的分析。
Ont Health Technol Assess Ser. 2009;9(10):1-40. Epub 2009 Sep 1.
4
[Comparative study of hypersensitive quantitative fecal immunochemical test and qualitative fecal occult blood test for colorectal cancer and advanced adenoma].[高敏定量粪便免疫化学检测与定性粪便潜血检测用于结直肠癌和进展期腺瘤的比较研究]
Zhonghua Yi Xue Za Zhi. 2022 Dec 13;102(46):3667-3672. doi: 10.3760/cma.j.cn112137-20220330-00663.
5
[Preliminary application of the Asia-Pacific colorectal screening score combined with the quantitative fecal occult blood in colorectal neoplasia screening].亚太结直肠癌筛查评分联合粪便隐血定量在结直肠肿瘤筛查中的初步应用
Zhonghua Yi Xue Za Zhi. 2021 Dec 14;101(46):3825-3828. doi: 10.3760/cma.j.cn112137-20210713-01558.
6
Association of time to colonoscopy after a positive fecal test result and fecal hemoglobin concentration with risk of advanced colorectal neoplasia.粪便潜血阳性后行结肠镜检查的时间和粪便血红蛋白浓度与结直肠高级别瘤变风险的关系。
Dig Liver Dis. 2019 Apr;51(4):589-594. doi: 10.1016/j.dld.2018.12.008. Epub 2018 Dec 23.
7
The fecal immunochemical test has high accuracy for detecting advanced colorectal neoplasia before age 50.粪便免疫化学检测在50岁之前检测晚期结直肠肿瘤方面具有很高的准确性。
Dig Liver Dis. 2017 May;49(5):557-561. doi: 10.1016/j.dld.2016.12.020. Epub 2016 Dec 24.
8
The Addition of Other Fecal Biomarkers Does Not Improve the Diagnostic Accuracy of Immunochemical Fecal Occult Blood Test Alone in a Colorrectal Cancer Screening Cohort.在结直肠癌筛查队列中,添加其他粪便生物标志物并不能提高单独免疫化学粪便潜血试验的诊断准确性。
Front Med (Lausanne). 2021 Jun 4;8:665786. doi: 10.3389/fmed.2021.665786. eCollection 2021.
9
Risk of missing colorectal cancer with a COVID-adapted diagnostic pathway using quantitative faecal immunochemical testing.定量粪便免疫化学检测 COVID 适应型诊断途径漏诊结直肠癌的风险。
BJS Open. 2021 Jul 6;5(4). doi: 10.1093/bjsopen/zrab056.
10

引用本文的文献

1
The Underlying Roles of Exosome-Associated PIGR in Fatty Acid Metabolism and Immune Signaling in Colorectal Cancer.外泌体相关PIGR在结直肠癌脂肪酸代谢和免疫信号传导中的潜在作用
J Oncol. 2022 Sep 15;2022:4675683. doi: 10.1155/2022/4675683. eCollection 2022.

本文引用的文献

1
The Effect of the Variability in Fecal Immunochemical Test Sample Collection Technique on Clinical Performance.粪便免疫化学检测样本采集技术的变异性对临床性能的影响。
Cancer Epidemiol Biomarkers Prev. 2021 Jan;30(1):175-181. doi: 10.1158/1055-9965.EPI-20-0984. Epub 2020 Oct 12.
2
Fecal Occult Blood Tests in Colorectal Cancer Screening: Systematic Review and Meta-analysis of Traditional and New-generation Fecal Immunochemical Tests.粪便潜血试验在结直肠癌筛查中的应用:传统和新一代粪便免疫化学试验的系统评价和荟萃分析。
Anticancer Res. 2020 Jul;40(7):3591-3604. doi: 10.21873/anticanres.14349.
3
Global Burden of 5 Major Types of Gastrointestinal Cancer.
全球 5 大常见胃肠道癌症负担
Gastroenterology. 2020 Jul;159(1):335-349.e15. doi: 10.1053/j.gastro.2020.02.068. Epub 2020 Apr 2.
4
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
5
Equivalent Accuracy of 2 Quantitative Fecal Immunochemical Tests in Detecting Advanced Neoplasia in an Organized Colorectal Cancer Screening Program.两种定量粪便免疫化学检测在有组织结直肠癌筛查项目中检测高级别腺瘤的准确性相当。
Gastroenterology. 2018 Nov;155(5):1392-1399.e5. doi: 10.1053/j.gastro.2018.07.021. Epub 2018 Jul 25.
6
Direct comparison of ten quantitative fecal immunochemical tests for hemoglobin stability in colorectal cancer screening.直接比较十种用于结直肠癌筛查的粪便免疫化学试验定量检测血红蛋白稳定性的比较。
Clin Transl Gastroenterol. 2018 Jul 6;9(7):168. doi: 10.1038/s41424-018-0035-2.
7
Performance of a quantitative fecal immunochemical test for detecting advanced colorectal neoplasia: a prospective cohort study.定量粪便免疫化学检测用于检测结直肠高级别瘤变的性能:一项前瞻性队列研究。
BMC Cancer. 2018 May 2;18(1):509. doi: 10.1186/s12885-018-4402-x.
8
Variation of diagnostic performance of fecal immunochemical testing for hemoglobin by sex and age: results from a large screening cohort.粪便免疫化学检测血红蛋白的诊断性能按性别和年龄的变化:来自一个大型筛查队列的结果。
Clin Epidemiol. 2018 Apr 5;10:381-389. doi: 10.2147/CLEP.S155548. eCollection 2018.
9
Risk of Interval Cancer in Fecal Immunochemical Test Screening Significantly Higher During the Summer Months: Results from the National Cancer Screening Program in Korea.粪便免疫化学试验筛查夏季间隔期癌症风险显著升高:来自韩国国家癌症筛查计划的结果。
Am J Gastroenterol. 2018 Apr;113(4):611-621. doi: 10.1038/ajg.2018.23. Epub 2018 Mar 6.
10
An evaluation of the SENTiFIT 270 analyser for quantitation of faecal haemoglobin in the investigation of patients with suspected colorectal cancer.评估 SENTiFIT 270 分析仪定量检测粪便血红蛋白在疑似结直肠癌患者中的应用。
Clin Chem Lab Med. 2018 Mar 28;56(4):625-633. doi: 10.1515/cclm-2017-0605.